North Dakota HB 1033: Relating to prescribing of biosimilar drugs.

Status: Filed with Secretary Of State 04/20 (as of 2021-04-21)

State: North Dakota · Session: 67 · Bill: HB 1033

Sponsors: Legislative Management

View North Dakota HB 1033 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.